Rachael Z

[NK papers @NK_papers]

ICB Response Is Associated with Pretreatment STAT1 Activation. by https://t.co/392DyZrXcV

[Science Translational Medicine @ScienceTM]

New research from @uwanews helps explain why many tumors are resistant to #checkpointblockade, and identifies a combination treatment that sensitized unresponsive tumors. https://t.co/0zdVtmwlBu

[Science Magazine @ScienceMagazine]

By comparing the genetic and cellular properties of various tumors, researchers in @ScienceTM have discovered why some #tumors are resistant to checkpoint inhibitors—a prominent form of #immunotherapy—in mice. https://t.co/uI9Pq4s4wK

[FDA Drug Information @FDA_Drug_Info]

FDA grants accelerated approval for drug that treats non-small cell lung cancer: http://t.co/hR3TeBzaFt

[Rachael Z @science_speakWA]

Combination immunotherapy has been fast tracked! impressive!
Nivolumab and Ipilimumab — NEJM http://t.co/g0DcSVoHvA https://t.co/M8SYxlLsqL

[Bristol Myers Squibb @bmsnews]

#MEDIA: The US #FDA has approved our combination of two #ImmunoOncology therapies http://t.co/vDlHTICmHe

[Rachael Z @science_speakWA]

#immunetherapy #PhD https://t.co/kN5tpmNUz6

[Oncology Central @OncologyCentral]

11 mths PFS w/ combined nivolumab/ipilimumab for #melanoma shown in Phase 3 study http://t.co/8e81JUfSKL #oncology

[Rachael Z @science_speakWA]

#phdlife https://t.co/yQROmWeNW8

[UWA @uwanews]

Congratulations to Marcus and Rachael! #3MT #UWAResearchWeek

[Rachael Z @science_speakWA]

That was intense! https://t.co/B3wVIRzoiy

[UWA @uwanews]

Finalists at #UWA's 3 Minute Thesis await the announcement of the winners! Results soon. #UWAResearchWeek #3MT

[Rachael Z @science_speakWA]

What an amazing thing to be able to capture! https://t.co/t5RF6IVsyr

[IIT @iit_ucl]

'Cytotoxic T Cell killing #Cancer Cells' (Source: NIHOD) #immunology @britsocimm https://t.co/dyy6MqCkqu